Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Landers CC"'
Autor:
Tothova Z, Krill-Burger JM, Popova KD, Landers CC, Sievers QL, Yudovich D, Belizaire R, Aster JC, Morgan EA, Tsherniak A, Ebert BL
Publikováno v:
Cell stem cell [Cell Stem Cell] 2024 Oct 03; Vol. 31 (10), pp. 1548-1549. Date of Electronic Publication: 2024 Sep 24.
Autor:
Landers CC; Department of Nutritional Sciences, University of Connecticut , Storrs, CT, USA., Rabeler CA; Department of Biology, Swarthmore College, Swarthmore, PA, USA., Ferrari EK; Children's Hospital of Philadelphia, Philadelphia, PA, USA., D'Alessandro LR; Department of Biology, Swarthmore College, Swarthmore, PA, USA., Kang DD; Division of Pharmaceutics and Pharmacology College of Pharmacy, Ohio State University, Columbus, OH, USA., Malisa J; Stanford University School of Medicine, Stanford, CA, USA., Bashir SM; Department of Biology, Swarthmore College, Swarthmore, PA, USA., Carone DM; Department of Biology, Swarthmore College, Swarthmore, PA, USA. dcarone1@swarthmore.edu.
Publikováno v:
Chromosoma [Chromosoma] 2021 Mar; Vol. 130 (1), pp. 75-90. Date of Electronic Publication: 2021 Feb 13.
Autor:
Tothova Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Valton AL; Program in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Gorelov RA; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Vallurupalli M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Krill-Burger JM; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Holmes A; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Landers CC; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Haydu JE; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Malolepsza E; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Hartigan C; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Donahue M; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Popova KD; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Koochaki S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Venev SV; Program in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA., Rivera J; Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom., Chen E; Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom., Lage K; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Schenone M; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., D'Andrea AD; Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Carr SA; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA., Morgan EA; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Dekker J; Program in Systems Biology, Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts, USA.; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA., Ebert BL; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cancer Program, Broad Institute, Cambridge, Massachusetts, USA.; Howard Hughes Medical Institute, Chevy Chase, Maryland, USA.
Publikováno v:
JCI insight [JCI Insight] 2021 Feb 08; Vol. 6 (3). Date of Electronic Publication: 2021 Feb 08.
Autor:
Tothova Z; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Krill-Burger JM; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Popova KD; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Landers CC; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Sievers QL; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02115, USA., Yudovich D; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Belizaire R; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Morgan EA; Department of Pathology, Brigham and Women's Hospital, Boston, MA 02115, USA., Tsherniak A; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Ebert BL; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02115, USA; Division of Hematology, Brigham and Women's Hospital, Boston, MA 02115, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: bebert@partners.org.
Publikováno v:
Cell stem cell [Cell Stem Cell] 2017 Oct 05; Vol. 21 (4), pp. 547-555.e8.